V7 Diagnostic Ultrasound System vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
V7 Diagnostic Ultrasound System
by Samsung Medison Co.
VS
Tempus ECG-AF
by Tempus AI, Inc.

AI Verdict

These tools are adjacent in their comparability, both offering AI-powered solutions within cardiology, but with distinct applications. The Samsung V7 is a diagnostic ultrasound system providing real-time imaging and AI-assisted measurements across various specialties, including detailed cardiac evaluations. In contrast, Tempus ECG-AF is a software-based algorithm specifically designed to predict the risk of atrial fibrillation in older patients based on ECG analysis, focusing on risk stratification rather than real-time imaging.

Choose V7 Diagnostic Ultrasound System if…

Choose the Samsung V7 Diagnostic Ultrasound System if your practice requires a versatile, high-performance ultrasound solution for comprehensive imaging across women's health, general imaging, and cardiovascular applications. Its AI-powered features like BiometryAssist™, UterineAssist™, and S-Shearwave Imaging™ are ideal for enhancing diagnostic precision and workflow efficiency in a busy clinical environment.

View V7 Diagnostic Ultrasound System →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if you need an AI-driven software solution to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, based on 12-lead ECG recordings. This tool is specifically designed for earlier identification and follow-up in patients without a pre-existing AF diagnosis, pacemakers, ICDs, or recent cardiac surgery.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature V7 Diagnostic Ultrasound System Tempus ECG-AF
Pricing Contact for pricing Contact vendor
Deployment On-premise (hardware) Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

V7 Diagnostic Ultrasound System

Tool A (Samsung V7) is a hardware system with a touch-based control panel and streamlined user interface designed for intuitive operation and efficient workflow in busy clinical settings. In contrast, Tool B (Tempus ECG-AF) is a software solution that integrates into existing systems and does not have a dedicated user interface, meaning its usability is dependent on the integration and the host system.

Clinical Value

V7 Diagnostic Ultrasound System

Tool A (Samsung V7) offers a broad range of AI-powered features for enhanced diagnostic precision across multiple specialties, including automated measurements for fetal biometry, uterine analysis, and tissue stiffness assessment. Tool B (Tempus ECG-AF) provides a specific AI-based algorithm for identifying patients at increased risk of atrial fibrillation, which is valuable but more narrowly focused.

Pricing & Value

Tempus ECG-AF

Tool B (Tempus ECG-AF) has transparent pricing details with CMS reimbursement available, including specific CPT codes and a Medicare rate. It also offers a self-pay option and financial assistance. Tool A (Samsung V7) requires contacting the vendor for pricing, making its value proposition less immediately clear, though some third-party sites list prices in a wide range.

Enterprise Readiness

Tie

Both tools demonstrate enterprise readiness through FDA clearance and HIPAA compliance. Tool A is an on-premise hardware system, suitable for direct integration into clinical workflows. Tool B is a software solution designed for integration into existing healthcare facility systems and EHRs, indicating its readiness for broader deployment within an enterprise infrastructure.

Innovation

V7 Diagnostic Ultrasound System

Tool A (Samsung V7) showcases innovation through its 'Crystal Architecture' for superior imaging and a wider array of AI-powered 'Intelligent Assist' features that automate complex measurements across diverse applications. While Tool B (Tempus ECG-AF) is innovative in its specific application of AI for AF risk prediction, Tool A's broader application of AI in imaging and diagnostic assistance demonstrates a wider scope of innovation.

Support & Docs

V7 Diagnostic Ultrasound System

Samsung provides extensive support for the V7, including warranty information, replacement parts, user manuals, and various contact options like live chat, email, and face-to-face support centers. Tempus ECG-AF offers technical support via email and phone, but the breadth of publicly available documentation and support channels appears more limited compared to Samsung's comprehensive offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature V7 Diagnostic Ultrasound System Tempus ECG-AF
Tool Name V7 Diagnostic Ultrasound System Tempus ECG-AF
Company Samsung Medison Co. Tempus AI, Inc.
Description High-performance, versatile ultrasound scanner featuring AI-powered tools and advanced imaging technology for superior diagnostic capabilities across women's health, general imaging, and cardiovascular applications. FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring V7 Diagnostic Ultrasound System and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The V7 Diagnostic Ultrasound System is a hardware-based solution that integrates into existing imaging workflows for cardiology, OB/GYN, and radiology, enhancing real-time diagnostics. Tempus ECG-AF is a software solution that integrates with existing 12-lead ECG systems (specifically GE Medical Systems and Philips Medical Systems) to analyze recordings and provide risk stratification for AF in patients 65 or older, fitting into cardiology and internal medicine workflows for risk assessment.
The V7 Diagnostic Ultrasound System, being a hardware device, would typically integrate with EHRs for image archiving and reporting, allowing physicians to access diagnostic images and reports. Tempus ECG-AF, as a software solution, is designed for integration into healthcare facility systems, suggesting a deeper potential for automated data flow of ECG analysis results directly into the EHR for physician review and follow-up within cardiology, geriatrics, and internal medicine.
The V7 Diagnostic Ultrasound System features AI-powered intelligent assist tools like BiometryAssistu2122 and UterineAssistu2122 for automated measurements, and 5D Heart Coloru2122 for semi-automated fetal heart evaluation, all aimed at enhancing diagnostic precision. Tempus ECG-AF is an FDA-cleared AI-based algorithm specifically trained on over 1.5 million ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within 12 months, providing a specific risk assessment.
For the V7 Diagnostic Ultrasound System, physicians in cardiology, OB/GYN, and radiology would need to learn to operate the advanced imaging features and AI-powered assists, which may involve a moderate learning curve typical of new ultrasound systems. Tempus ECG-AF, being an algorithmic analysis of existing ECGs, would likely have a lower learning curve for physicians in cardiology, geriatrics, and internal medicine, as it primarily involves interpreting the risk stratification output rather than operating new hardware.
The V7 Diagnostic Ultrasound System, as an imaging device, would typically maintain an audit trail of imaging studies performed and potentially any automated measurements generated by its AI features within the saved reports. Tempus ECG-AF, as an AI algorithm providing risk assessment, would likely offer robust audit-trail features to track when an ECG was analyzed, the algorithm's output, and potentially who reviewed the results, which is crucial for clinical decision-making and accountability in cardiology, geriatrics, and internal medicine.
For the V7 Diagnostic Ultrasound System, multi-site rollout would involve deploying hardware at each location, requiring consistent training for sonographers and physicians to ensure standardized image acquisition and interpretation across sites. Tempus ECG-AF, being a software solution, could potentially be rolled out more uniformly across multiple sites through system integration, with consistent algorithmic analysis ensuring standardized risk assessment for AF across different clinical settings in cardiology, geriatrics, and internal medicine, though training on result interpretation would still be necessary.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring V7 Diagnostic Ultrasound System or Tempus ECG-AF

Backers

Who funded each tool's parent company.

Tempus ECG-AF

AI Tool Finder
AI-powered search. Results may not be comprehensive.